NeuroOne Medical Technologies Corporation NMTC
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -79.62%
- 1 year
- -80.48%
- Open
- 0.97
- Prev close
- 0.9698
- Mkt cap
- 8.44M
- Vol
- 33.83K
- Avg vol
- 346.82K
- EPS
- -0.99
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.87
- High
- 1.02
- Forward P/E
- -2.65
- Beta
- 0.91
- Short ratio
- 0.60
- Inst. own
- 19.43%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.81312
- 200-d avg
- 0.92463
- 1y target
- 0.00
News
-
3 days ago benzinga.com
NeuroOne Medical Technologies Publishes Initial Clinical Results For Its OneRF Trigeminal Nerve Ablation System
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on the surgical diagnosis and treatment of neurological disorders, today
3 days ago globenewswire.com
NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System
Study Reports Immediate Pain Freedom in 14 of 15 Patients; all Patients Achieved Favorable Pain Outcomes at a Mean Six-Month Follow-Up Multi-Contact Probe Technology Enabled Mapping and Treatment of…
5 days ago globenewswire.com
NeuroOne Featured in New York Post on OneRF® Patient's Remarkable Journey to Overcome Debilitating Facial Pain
NeuroOne's FDA 510(k)-Cleared OneRF Trigeminal Nerve Ablation System Offers Hope for Patients Suffering from Trigeminal Neuralgia EDEN PRAIRIE, Minn., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NeuroOne…
1 week ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 41.9% to $0.46 during Thursday's after-market session. The company's market cap stands at $67.1 million. Aardvark Therapeutics…
-
1 week ago benzinga.com
NeuroOne Secures First Pharmaceutical Industry Purchase Order For StereoCED Drug Delivery Platform; No Terms Disclosed
Major Commercial Milestone Represents Important Step Toward Potential Long-Term Collaborations with Global Pharmaceutical CompaniesEDEN PRAIRIE, Minn., Oct. 22, 2026 (GLOBE NEWSWIRE) -- NeuroOne…
1 week ago globenewswire.com
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Research
2 weeks ago defenseworld.net
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Stock Short Interest Climbs 135.8%
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 30th, there was…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…
3 weeks ago globenewswire.com
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
New NIH Award will Initially Provide NeuroOne Approximately $200,000 through April 2027 EDEN PRAIRIE, Minn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…
3 weeks ago defenseworld.net
NeuroOne (NASDAQ: NMTC) secures a $4.5M order as revenue climbs again
What happened NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) said preliminary fourth-quarter product revenue was $3.8 million. That was up 38.4% from $2.7 million a year earlier. The…
-
3 weeks ago benzinga.com
NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological
3 weeks ago globenewswire.com
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million Preliminary Full-Year Product Revenue Up 15.6% to $10.5 Million, at the Top of Guidance Range EDEN PRAIRIE, Minn., Oct. 05, 2026 (GLOBE…
4 weeks ago defenseworld.net
Innovative Eyewear (NASDAQ:LUCY) and NeuroOne Medical Technologies (NASDAQ:NMTC) Head-To-Head Review
NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) and Innovative Eyewear (NASDAQ: LUCY - Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We…
1 month ago gurufocus.com
$10 Million in New Markets Tax Credit Financing for a New cold Storage and Refrigerated Logistics Facility in Albertville, AL
$10 Million in New Markets Tax Credit Financing for a New cold Storage and Refrigerated Logistics Facility in Albertville, ALPR NewswireATMORE, Ala., Oct. 2, 20
1 month ago defenseworld.net
Analysts Set NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Price Target at $7.33
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have earned a consensus recommendation of "Hold" from the five research firms that are presently covering the…
1 month ago globenewswire.com
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
EDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming…
-
1 month ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 8.9% to $0.32 during Thursday's after-market session. The company's market cap stands at $11.5 million. Picard Medical (AMEX:PMI) stock moved…
-
2 months ago benzinga.com
NeuroOne Completes Three Large-Animal StereoCED Procedures, Including Combined Drug Delivery And Brain Recording; Builds Momentum Toward Planned Launch Of The StereoCED Platform For Human Investigational Clinical Studies Later This Quarter
Successful Large-Animal Procedures Build Momentum Toward Planned Launch of the StereoCED™ Platform for Human Investigational Clinical Studies Later This Quarter Related StereoCED™ Revenue Expected to…
2 months ago gurufocus.com
$6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a Tractor Assembly Facility in Monroeville, AL
$6 Million in New Markets Tax Credit Financing for the Acquisition, Renovation, and Equipping of a Tractor Assembly Facility in Monroeville, AL
-
2 months ago benzinga.com
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5
Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.
2 months ago seekingalpha.com
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
5 months ago benzinga.com
NeuroOne Medical Tech Q2 2026 Earnings Call Transcript
NeuroOne Medical Tech Q2 2026 Earnings Call Transcript
5 months ago seekingalpha.com
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript
-
5 months ago benzinga.com
NeuroOne Medical Tech Q2 EPS $(0.25) Misses $(0.23) Estimate, Sales $2.391M Miss $2.576M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 40.48 percent increase over losses…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
7 months ago defenseworld.net
Analyzing First Choice Healthcare Solutions (OTCMKTS:FCHS) & NeuroOne Medical Technologies (NASDAQ:NMTC)
First Choice Healthcare Solutions (OTCMKTS:FCHS - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior…
7 months ago seekingalpha.com
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript
8 months ago defenseworld.net
Brokerages Set NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) PT at $1.98
Shares of NeuroOne Medical Technologies Corporation (NASDAQ: NMTC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the five analysts that are covering the firm,…
-
8 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
8 months ago benzinga.com
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5
Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.5.
8 months ago seekingalpha.com
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript
8 months ago benzinga.com
Insights into NeuroOne Medical Tech Q1 Earnings
Insights into NeuroOne Medical Tech Q1 Earnings
-
8 months ago benzinga.com
NeuroOne Medical Tech Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $2.893M Beat $2.678M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.04) by 25 percent. This is a 150 percent decrease over earnings of…
-
8 months ago benzinga.com
Earnings Scheduled For February 17, 2026
Earnings Scheduled For February 17, 2026
8 months ago benzinga.com
What to Expect from NeuroOne Medical Tech's Earnings
What to Expect from NeuroOne Medical Tech's Earnings
8 months ago defenseworld.net
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast
Aclarion (NASDAQ: ACON - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the…
9 months ago defenseworld.net
Contrasting NeuroOne Medical Technologies (NASDAQ:NMTC) and Cannlabs (OTCMKTS:CANL)
Cannlabs (OTCMKTS:CANL - Get Free Report) and NeuroOne Medical Technologies (NASDAQ: NMTC - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two…
9 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
-
10 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
10 months ago benzinga.com
NeuroOne Medical Tech Q4 EPS $(0.04), Inline, Sales $2.741M Beat $2.470M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. This is a 63.64 percent increase over losses of $(0.11) per share from the…
-
1 year ago benzinga.com
NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand
Preliminary Results On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results: ●Achieved annual total product revenue of
-
1 year ago benzinga.com
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3
Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $3.
-
1 year ago benzinga.com
NeuroOne Medical Tech Affirms FY2025 Sales Guidance of $8.00M-$10.00M vs $8.71M Est
NeuroOne Medical Tech (NASDAQ:NMTC) affirms FY2025 sales outlook from $8.00 million-$10.00 million to $8.00 million-$10.00 million vs $8.71 million estimate.
-
1 year ago benzinga.com
NeuroOne Medical Tech Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $1.70M Miss $1.82M Estimate
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 70 percent increase over losses of…
-
1 year ago benzinga.com
Earnings Scheduled For August 14, 2025
Earnings Scheduled For August 14, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session